Literature DB >> 15625406

EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.

Vikram Jadhav1, Anthony Jabre, Shinn-Zong Lin, Tony Jer-Fu Lee.   

Abstract

Prostaglandin E2 (PGE2) has been shown to dilate and constrict the systemic vascular beds, including cerebral vessels. The exact mechanism of PGE2-induced cerebral vasoconstriction, however, is less clarified. The authors' preliminary studies showed that PGE2 exclusively constricted the adult porcine basilar arteries. The present study, therefore, was designed to examine the receptor mechanisms involved in PGE2-induced constriction of large cerebral arteries in the adult pig. Results from an in vitro tissue-bath study indicated that PGE2 and its agonists 17-phenyl trinor PGE2 (17-PGE2), sulprostone (EP1/EP3 receptor agonists), and 11-deoxy-16,16-dimethyl PGE2 (11-PGE2, an EP2/EP3-receptor agonist) induced exclusive constriction, which was not affected by endothelium denudation or cold-storage denervation of perivascular nerves. The constriction induced by PGE2, 17-PGE2, and sulprostone, but not by potassium chloride, was blocked by SC-19220 (a selective EP1-receptor antagonist), AH-6809 (an EP1/EP2-receptor antagonist), and U-73122 and neomycin (phospholipase C inhibitors). AH-6809, however, did not affect 11-PGE2-induced contraction. These results suggest that the contraction was not mediated by the EP2-receptor, but was mediated by EP1- and EP3-receptors. Furthermore, EP1-receptor immunoreactivities were found across the entire medial smooth muscle layers, whereas EP3-receptor immunoreactivities were limited to the outer smooth muscle layer toward the adventitia. Western blotting also showed the presence of EP1- and EP3-receptor proteins in cultured primary cerebral vascular smooth muscle cells. In conclusion, PGE2 exclusively constricts the adult porcine large cerebral arteries. This constriction is mediated by phosphatidyl-inositol pathway via activation of EP1- and EP3-receptors located on the smooth muscle cells. These two receptor subtypes may play important roles in physiologic and pathophysiologic control of cerebral vascular tone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625406     DOI: 10.1097/01.WCB.0000139446.61789.14

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  30 in total

Review 1.  Potassium channels and neurovascular coupling.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Circ J       Date:  2010-03-16       Impact factor: 2.993

2.  Impaired blood pressure recovery to hemorrhage in obese Zucker rats with orthopedic trauma.

Authors:  Lusha Xiang; Silu Lu; William Fuller; Arun Aneja; George V Russell; Louis B Jones; Robert Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

3.  Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.

Authors:  Miao Wang; Alicia M Zukas; Yiqun Hui; Emanuela Ricciotti; Ellen Puré; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

4.  Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury.

Authors:  Muzamil Ahmad; Abdullah Shafique Ahmad; Hean Zhuang; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2007-02-02       Impact factor: 3.478

5.  Contractile function of the cervix plays a role in normal and pathological pregnancy and parturition.

Authors:  Ourlad Alzeus G Tantengco; Ramkumar Menon
Journal:  Med Hypotheses       Date:  2020-10-07       Impact factor: 1.538

6.  Protein kinase C delta contributes to increase in EP3 agonist-induced contraction in mesenteric arteries from type 2 diabetic Goto-Kakizaki rats.

Authors:  Keiko Ishida; Takayuki Matsumoto; Kumiko Taguchi; Katsuo Kamata; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2012-02-28       Impact factor: 3.657

7.  Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptors.

Authors:  S Ayabe; T Murata; T Maruyama; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

8.  The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.

Authors:  Anna Theiler; Viktoria Konya; Lisa Pasterk; Jovana Maric; Thomas Bärnthaler; Ilse Lanz; Wolfgang Platzer; Rufina Schuligoi; Akos Heinemann
Journal:  Vascul Pharmacol       Date:  2016-09-21       Impact factor: 5.773

9.  Adenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury.

Authors:  Jian Zhou; Martha B Alvarez-Elizondo; Elliot Botvinick; Steven C George
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-06       Impact factor: 6.914

Review 10.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.